Information Journal Paper
APA:
Copy. (2018). The somatostatin receptor 2 antagonist 64Cu-NODAGA-JR11 outperforms 64Cu-DOTA-TATE in a mouse xenograft model. PLOS ONE, 13(4), 1-16. SID. https://sid.ir/paper/783687/en
Vancouver:
Copy. The somatostatin receptor 2 antagonist 64Cu-NODAGA-JR11 outperforms 64Cu-DOTA-TATE in a mouse xenograft model. PLOS ONE[Internet]. 2018;13(4):1-16. Available from: https://sid.ir/paper/783687/en
IEEE:
Copy, “The somatostatin receptor 2 antagonist 64Cu-NODAGA-JR11 outperforms 64Cu-DOTA-TATE in a mouse xenograft model,” PLOS ONE, vol. 13, no. 4, pp. 1–16, 2018, [Online]. Available: https://sid.ir/paper/783687/en